NCT03950960View on ClinicalTrials.gov

A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of BMS-986256 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

July 31, 2019

Study Completion Date

August 7, 2019

Conditions
Healthy Participants
Interventions
DRUG

BMS-986256

Specified dose on specified days

DRUG

Itraconazole

Specified dose on specified days

Trial Locations (1)

66219

PRA Health Sciences - Lenexa, Lenexa

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY